Antibiotic therapy effects on lipidFoxidizing Chlamydia Pneumoniae antibodies in coronary heart disease patients

1. Nieto F.J., Folsom A.R., Sorlie P.D., Grayston J.T., Wang S.P., Chambless L.E. Chlamydia pneumoniae and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150: 149-56.

2. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2 (8618): 983-986.

3. Saikku P., Leinonen M., Tenkanen L. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273-278.

4. Danesh J., Whincup P., Walker M., Lennon L., Thomson A. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. ВМJ 2000; 321(7255): 208-213.

5. Ridker P.M., Kundsin R.B., Stampfer M.J., Poulin S., Hennekens C.H. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999; 99: 1161-1164.

6. Басинкевич А.Б., Шахнович P.M., Мартынова В.Р., Колкова Н.И., Раковская И.В., Каражас Н.В., Евсеева Л.Ф., Добровольский А.Б., Деев А.Д., Ноева Е.А., Руда М.Я. Роль хламидийной, микоплазменной и цитомегаловирусной инфекций в развитии ишемической болезни сердца. // Кардиология. 2003. № 11. С. 4-9.

7. Fryer R.H., Schwobe E.P., Woods M.L., Rodgers G.M. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med. 1997; 45: 168-174.

8. Petyaev I.M., Milner J. Means for treatment of atherosclerosis. UK Patent № 0219602. 0 (09.04.2003).

9. Фисенко В.П., Чичкова Н.В. О противовоспалительных свойствах макролидов. // Врач. 2005. № 2. С. 50-52.

10. Brown D.L., Desai К.К., Vakili B.A., Nouneh С., Lee H.M., Golub L.M. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler Thromb Vase Biol 2004; 24: 733-738.